Skip to main content
. 2018 Jul 6;37(45):5926–5938. doi: 10.1038/s41388-018-0394-x

Fig. 3.

Fig. 3

HMGA1 depletion in MLS trabectedin-resistant cells inhibits cell migration and invasion and favors responsiveness to the drug. a Chemotaxis and chemoinvasion assays were performed to examine the effect of HMGA1 depletion on 402-91 ET cells. Number of migrated and invading cells was presented as the means ± SD of triplicate experiments of each group (P < 0.001 and P < 0.0001, respectively). b Cell death of 402-91 WT and 402-91 ET cells, upon trabectedin treatment for the indicated time, were evaluated by Trypan blue exclusion from three independent experiments (P < 0.0001) (upper panel); total cell lysates were evaluated by WB for the expression of PARP and Hsp70 (lower panel). c 402-91 WT and 402-91 ET cells, upon depletion with HMGA1 expression, were treated for 48 h with trabectedin. Total cell lysates, derived from siScr and siHMGA1 untreated or treated cells were analyzed by WB for the expression of HMGA1, PARP, and Hsp70 (lower panel). Cell death was evaluated by Trypan blue exclusion from three independent experiments (P < 0.001) (upper panel)